Stay updated with breaking news from Cagent Vascular. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
June 1, 2022—Cagent Vascular, Inc. announced the commercial launch of the Serranator above-the-knee (ATK) product. An expansion of their current
Press release content from Business Wire. The AP news staff was not involved in its creation. Cagent Vascular Announces PRELUDE-BTK Study Results Presented at LINC Symposium: Confirms Serranator Device Novel Mechanism of Action February 1, 2021 GMT WAYNE, Pa.--(BUSINESS WIRE)--Feb 1, 2021-- Cagent Vascular, a developer of serration technology for vessel dilatation in endovascular interventions, announced the results of its PRELUDE-BTK Study at this year’s LINC Symposium on January 29th. The PRELUDE-BTK Study, was a prospective, single-arm, multi-center feasibility study to show the safety a...